Enrolled Copy H.B. 84
1
Vaccine Amendments
2025 GENERAL SESSION
STATE OF UTAH
Chief Sponsor: Trevor Lee
Senate Sponsor: Keith Grover
2
3
LONG TITLE
4
General Description:
5
This bill addresses vaccines or vaccine material.
6
Highlighted Provisions:
7
This bill:
8
▸ defines terms;
9
▸ designates food intended for human consumption that intentionally contains a vaccine or
10
vaccine material as a drug; and
11
▸ makes technical amendments.
12
Money Appropriated in this Bill:
13
None
14
Other Special Clauses:
15
None
16
Utah Code Sections Affected:
17
AMENDS:
18
26B-7-108, as renumbered and amended by Laws of Utah 2023, Chapter 308
19
58-37-2, as last amended by Laws of Utah 2024, Chapter 35
20
ENACTS:
21
4-5-107, Utah Code Annotated 1953
22
23
Be it enacted by the Legislature of the state of Utah:
24
Section 1. Section 4-5-107 is enacted to read:
25
4-5-107 . Food containing vaccine.
26
(1) As used in this section, "vaccine or vaccine material" means a substance that is:
27
(a) intended for use in humans to stimulate the production of antibodies and provide
28
immunity against disease; H.B. 84 Enrolled Copy
29
(b) prepared from the causative agent of a disease, the disease's products, or a synthetic
30
substitute treated to act as an antigen without including the disease; and
31
(c) authorized or approved by the United States Food and Drug Administration.
32
(2) A food intended for human consumption that intentionally contains a vaccine or vaccine
33
material is considered a drug for purposes of this chapter, Section 26B-7-108, and Title
34
58, Chapter 37, Utah Controlled Substances Act.
35
Section 2. Section 26B-7-108 is amended to read:
36
26B-7-108 . Rules for sale of drugs, cosmetics, and medical devices.
37
(1) The department shall [establish] make rules, in accordance with Title 63G, Chapter
38
3, Utah Administrative Rulemaking Act, and enforce the rules for the sale or distribution
39
of human drugs, cosmetics, and medical devices.
40
(2) Food intended for human consumption that intentionally contains a vaccine or vaccine
41
material is considered a human drug for purposes of this section as provided in Section
42
4-5-107.
43
(3) The rules adopted under this section shall be no more stringent than those established by
44
federal law.
45
Section 3. Section 58-37-2 is amended to read:
46
58-37-2 . Definitions.
47
(1) As used in this chapter:
48
(a) "Administer" means the direct application of a controlled substance, whether by
49
injection, inhalation, ingestion, or any other means, to the body of a patient or
50
research subject by:
51
(i) a practitioner or, in the practitioner's presence, by the practitioner's authorized
52
agent; or
53
(ii) the patient or research subject at the direction and in the presence of the
54
practitioner.
55
(b) "Agent" means an authorized person who acts on behalf of or at the direction of a
56
manufacturer, distributor, or practitioner but does not include a motor carrier, public
57
warehouseman, or employee of any of them.
58
(c) "Consumption" means ingesting or having any measurable amount of a controlled
59
substance in a person's body, but this Subsection (1)(c) does not include the
60
metabolite of a controlled substance.
61
(d) "Continuing criminal enterprise" means any individual, sole proprietorship,
62
partnership, corporation, business trust, association, or other legal entity, and any
- 2 - Enrolled Copy H.B. 84
63
union or groups of individuals associated in fact although not a legal entity, and
64
includes illicit as well as licit entities created or maintained for the purpose of
65
engaging in conduct which constitutes the commission of episodes of activity made
66
unlawful by [Chapter 37, Utah Controlled Substances Act] this chapter, Chapter 37a,
67
Utah Drug Paraphernalia Act, Chapter 37b, Imitation Controlled Substances Act,
68
Chapter 37c, Utah Controlled Substance Precursor Act, or Chapter 37d, Clandestine
69
Drug Lab Act, which episodes are not isolated, but have the same or similar
70
purposes, results, participants, victims, methods of commission, or otherwise are
71
interrelated by distinguishing characteristics. Taken together, the episodes shall
72
demonstrate continuing unlawful conduct and be related either to each other or to the
73
enterprise.
74
(e) "Control" means to add, remove, or change the placement of a drug, substance, or
75
immediate precursor under Section 58-37-3.
76
(f)(i) "Controlled substance" means a drug or substance:
77
(A) included in Schedules I, II, III, IV, or V of Section 58-37-4;
78
(B) included in Schedules I, II, III, IV, or V of the federal Controlled Substances
79
Act, Title II, P.L. 91-513;
80
(C) that is a controlled substance analog; or
81
(D) listed in Section 58-37-4.2.
82
(ii) "Controlled substance" does not include:
83
(A) distilled spirits, wine, or malt beverages, as those terms are defined in Title
84
32B, Alcoholic Beverage Control Act;
85
(B) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment,
86
or prevention of disease in human or other animals, which contains ephedrine,
87
pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if the drug is
88
lawfully purchased, sold, transferred, or furnished as an over-the-counter
89
medication without prescription; or
90
(C) dietary supplements, vitamins, minerals, herbs, or other similar substances
91
including concentrates or extracts, which:
92
(I) are not otherwise regulated by law; and
93
(II) may contain naturally occurring amounts of chemical or substances listed
94
in this chapter, or in rules adopted pursuant to Title 63G, Chapter 3, Utah
95
Administrative Rulemaking Act.
96
(g)(i) "Controlled substance analog" means:
- 3 - H.B. 84 Enrolled Copy
97
(A) a substance the chemical structure of which is substantially similar to the
98
chemical structure of a controlled substance listed in Schedules I and II of
99
Section 58-37-4, a substance listed in Section 58-37-4.2, or in Schedules I and
100
II of the federal Controlled Substances Act, Title II, P.L. 91-513;
101
(B) a substance [which] that has a stimulant, depressant, or hallucinogenic effect
102
on the central nervous system substantially similar to the stimulant, depressant,
103
or hallucinogenic effect on the central nervous system of controlled substances
104
listed in Schedules I and II of Section 58-37-4, substances listed in Section
105
58-37-4.2, or substances listed in Schedules I and II of the federal Controlled
106
Substances Act, Title II, P.L. 91-513; or
107
(C) A substance [which] that, with respect to a particular individual, is represented
108
or intended to have a stimulant, depressant, or hallucinogenic effect on the
109
central nervous system substantially similar to the stimulant, depressant, or
110
hallucinogenic effect on the central nervous system of controlled substances
111
listed in Schedules I and II of Section 58-37-4, substances listed in Section
112
58-37-4.2, or substances listed in Schedules I and II of the federal Controlled
113
Substances Act, Title II, P.L. 91-513.
114
(ii) "Controlled substance analog" does not include:
115
(A) a controlled substance currently scheduled in Schedules I through V of
116
Section 58-37-4;
117
(B) a substance for which there is an approved new drug application;
118
(C) a substance with respect to which an exemption is in effect for investigational
119
use by a particular person under Section 505 of the Food, Drug, and Cosmetic
120
Act, 21 U.S.C. 355, to the extent the conduct with respect to the substance is
121
permitted by the exemption;
122
(D) any substance to the extent not intended for human consumption before an
123
exemption takes effect with respect to the substance;
124
(E) any drug intended for lawful use in the diagnosis, cure, mitigation, treatment,
125
or prevention of disease in man or other animals, which contains ephedrine,
126
pseudoephedrine, norpseudoephedrine, or phenylpropanolamine if the drug is
127
lawfully purchased, sold, transferred, or furnished as an over-the-counter
128
medication without prescription; or
129
(F) dietary supplements, vitamins, minerals, herbs, or other similar substances
130
including concentrates or extracts, which are not otherwise regulated by law,
- 4 - Enrolled Copy H.B. 84
131
which may contain naturally occurring amounts of chemical or substances
132
listed in this chapter, or in rules adopted pursuant to Title 63G, Chapter 3, Utah
133
Administrative Rulemaking Act.
134
(h)(i) "Conviction" means a determination of guilt by verdict, whether jury or bench,
135
or plea, whether guilty or no contest, for any offense proscribed by:
136
(A) [Chapter 37, Utah Controlled Substances Act] this chapter;
137
(B) Chapter 37a, Utah Drug Paraphernalia Act;
138
(C) Chapter 37b, Imitation Controlled Substances Act;
139
(D) Chapter 37c, Utah Controlled Substance Precursor Act; or
140
(E) Chapter 37d, Clandestine Drug Lab Act; or
141
(ii) for any offense under the laws of the United States and any other state which, if
142
committed in this state, would be an offense under:
143
(A) [Chapter 37, Utah Controlled Substances Act] this chapter;
144
(B) Chapter 37a, Utah Drug Paraphernalia Act;
145
(C) Chapter 37b, Imitation Controlled Substances Act;
146
(D) Chapter 37c, Utah Controlled Substance Precursor Act; or
147
(E) Chapter 37d, Clandestine Drug Lab Act.
148
(i) "Counterfeit substance" means:
149
(i) any controlled substance or container or labeling of any controlled substance that:
150
(A) without authorization bears the trademark, trade name, or other identifying
151
mark, imprint, number, device, or any likeness of them, of a manufacturer,
152
distributor, or dispenser other than the person or persons who in fact
153
manufactured, distributed, or dispensed the substance which falsely purports to
154
be a controlled substance distributed by any other manufacturer, distributor, or
155
dispenser; and
156
(B) a reasonable person would believe to be a controlled substance distributed by
157
an authorized manufacturer, distributor, or dispenser based on the appearance
158
of the substance as described under Subsection (1)(i)(i)(A) or the appearance of
159
the container of that controlled substance; or
160
(ii) any substance other than under Subsection (1)(i)(i) that:
161
(A) is falsely represented to be any legally or illegally manufactured controlled
162
substance; and
163
(B) a reasonable person would believe to be a legal or illegal controlled substance.
164
(j) "Deliver" or "delivery" means the actual, constructive, or attempted transfer of a
- 5 - H.B. 84 Enrolled Copy
165
controlled substance or a listed chemical, whether or not an agency relationship exists.
166
(k) "Department" means the Department of Commerce.
167
(l) "Depressant or stimulant substance" means:
168
(i) a drug which contains any quantity of barbituric acid or any of the salts of
169
barbituric acid;
170
(ii) a drug which contains any quantity of:
171
(A) amphetamine or any of its optical isomers;
172
(B) any salt of amphetamine or any salt of an optical isomer of amphetamine; or
173
(C) any substance which the Secretary of Health and Human Services or the
174
Attorney General of the United States after investigation has found and by
175
regulation designated habit-forming because of its stimulant effect on the
176
central nervous system;
177
(iii) lysergic acid diethylamide; or
178
(iv) any drug which contains any quantity of a substance which the Secretary of
179
Health and Human Services or the Attorney General of the United States after
180
investigation has found to have, and by regulation designated as having, a
181
potential for abuse because of its depressant or stimulant effect on the central
182
nervous system or its hallucinogenic effect.
183
(m) "Dispense" means the delivery of a controlled substance by a pharmacist to an
184
ultimate user pursuant to the lawful order or prescription of a practitioner, and
185
includes distributing to, leaving with, giving away, or disposing of that substance as
186
well as the packaging, labeling, or compounding necessary to prepare the substance
187
for delivery.
188
(n) "Dispenser" means a pharmacist who dispenses a controlled substance.
189
(o) "Distribute" means to deliver other than by administering or dispensing a controlled
190
substance or a listed chemical.
191
(p) "Distributor" means a person who distributes controlled substances.
192
(q) "Division" means the Division of Professional Licensing created in Section 58-1-103.
193
(r)(i) "Drug" means:
194
(A) a substance recognized in the official United States Pharmacopoeia, Official
195
Homeopathic Pharmacopoeia of the United States, or Official National
196
Formulary, or any supplement to any of them, intended for use in the
197
diagnosis, cure, mitigation, treatment, or prevention of disease in humans or
198
animals;
- 6 - Enrolled Copy H.B. 84
199
(B) a substance that is required by any applicable federal or state law or rule to be
200
dispensed by prescription only or is restricted to administration by practitioners
201
only;
202
(C) a substance other than food intended to affect the structure or any function of
203
the body of humans or other animals; and
204
(D) substances intended for use as a component of any substance specified in
205
Subsections (1)(r)(i)(A), (B), and (C).
206
(ii) "Drug" does not include dietary supplements.
207
(iii) "Drug" includes a food intended for human consumption that intentionally
208
contains a vaccine or vaccine material as provided in Section 4-5-107.
209
(s) "Drug dependent person" means any individual who unlawfully and habitually uses
210
any controlled substance to endanger the public morals, health, safety, or welfare, or
211
who is so dependent upon the use of controlled substances as to have lost the power
212
of self-control with reference to the individual's dependency.
213
(t)(i) "Food" means:
214
[(i)] (A) any nutrient or substance of plant, mineral, or animal origin other than a
215
drug as specified in this chapter, and normally ingested by human beings; and
216
[(ii)] (B) foods for special dietary uses as exist by reason of a physical,
217
physiological, pathological, or other condition including[ but not limited to] the
218
conditions of disease, convalescence, pregnancy, lactation, allergy,
219
hypersensitivity to food, underweight, and overweight; uses for supplying a
220
particular dietary need which exist by reason of age including[ but not limited
221
to] the ages of infancy and childbirth, and also uses for supplementing and for
222
fortifying the ordinary or unusual diet with any vitamin, mineral, or other
223
dietary property for use of a food.
224
(ii) Any particular use of a food is a special dietary use regardless of the nutritional
225
purposes.
226
(u) "Immediate precursor" means a substance which the Attorney General of the United
227
States has found to be, and by regulation designated as being, the principal compound
228
used or produced primarily for use in the manufacture of a controlled substance, or
229
which is an immediate chemical intermediary used or likely to be used in the
230
manufacture of a controlled substance, the control of which is necessary to prevent,
231
curtail, or limit the manufacture of the controlled substance.
232
(v) "Indian" means a member of an Indian tribe.
- 7 - H.B. 84 Enrolled Copy
233
(w) "Indian religion" means [any] a religion:
234
(i) the origin and interpretation of which is from within a traditional Indian culture or
235
community; and
236
(ii) [which] that is practiced by Indians.
237
(x) "Indian tribe" means any tribe, band, nation, pueblo, or other organized group or
238
community of Indians, including any Alaska Native village, which is legally
239
recognized as eligible for and is consistent with the special programs, services, and
240
entitlements provided by the United States to Indians because of their status as
241
Indians.
242
(y) "Manufacture" means the production, preparation, propagation, compounding, or
243
processing of a controlled substance, either directly or indirectly by extraction from
244
substances of natural origin, or independently by means of chemical synthesis or by a
245
combination of extraction and chemical synthesis.
246
(z) "Manufacturer" includes any person who packages, repackages, or labels any
247
container of any controlled substance, except pharmacists who dispense or compound
248
prescription orders for delivery to the ultimate consumer.
249
(aa)(i) "Marijuana" means all species of the genus cannabis and all parts of the genus,
250
whether growing or not, including:
251
(A) seeds;
252
(B) resin extracted from any part of the plant, including the resin extracted from
253
the mature stalks;
254
(C) every compound, manufacture, salt, derivative, mixture, or preparation of the
255
plant, seeds, or resin;
256
(D) any synthetic equivalents of the substances contained in the plant cannabis
257
sativa or any other species of the genus cannabis which are chemically
258
indistinguishable and pharmacologically active; and
259
(E) any component part or cannabinoid extracted or isolated from the plant,
260
including extracted or isolated tetrahydrocannabinols.
261
(ii) "Marijuana" does not include:
262
(A) the mature stalks of the plant;
263
(B) fiber produced from the stalks;
264
(C) oil or cake made from the seeds of the plant;
265
(D) except as provided in Subsection (1)(aa)(i), any other compound,
266
manufacture, salt, derivative, mixture, or preparation of the mature stalks,
- 8 - Enrolled Copy H.B. 84
267
fiber, oil or cake;
268
(E) the sterilized seed of the plant which is incapable of germination;
269
(F) any compound, mixture, or preparation approved by the federal Food and
270
Drug Administration under the federal Food, Drug, and Cosmetic Act, 21
271
U.S.C. Sec. 301 et seq. that is not listed in a schedule of controlled substances
272
in Section 58-37-4 or in the federal Controlled Substances Act, Title II, P.L.
273
91-513; or
274
(G) transportable industrial hemp concentrate as that term is defined in Section
275
4-41-102.
276
(bb) "Money" means officially issued coin and currency of the United States or any
277
foreign country.
278
(cc) "Narcotic drug" means any of the following, whether produced directly or indirectly
279
by extraction from substances of vegetable origin, or independently by means of
280
chemical synthesis, or by a combination of extraction and chemical synthesis:
281
(i) opium, coca leaves, and opiates;
282
(ii) a compound, manufacture, salt, derivative, or preparation of opium, coca leaves,
283
or opiates;
284
(iii) opium poppy and poppy straw; or
285
(iv) a substance, and any compound, manufacture, salt, derivative, or preparation of
286
the substance, which is chemically identical with any of the substances referred to
287
in Subsection (1)(cc)(i), (ii), or (iii), except narcotic drug does not include
288
decocainized coca leaves or extracts of coca leaves which do not contain cocaine
289
or ecgonine.
290
(dd) "Negotiable instrument" means documents, containing an unconditional promise to
291
pay a sum of money, which are legally transferable to another party by endorsement
292
or delivery.
293
(ee) "Opiate" means any drug or other substance having an addiction-forming or
294
addiction-sustaining liability similar to morphine or being capable of conversion into
295
a drug having addiction-forming or addiction-sustaining liability.
296
(ff) "Opium poppy" means the plant of the species papaver somniferum L., except the
297
seeds of the plant.
298
(gg) "Person" means any corporation, association, partnership, trust, other institution or
299
entity or one or more individuals.
300
(hh) "Poppy straw" means all parts, except the seeds, of the opium poppy, after mowing.
- 9 - H.B. 84 Enrolled Copy
301
(ii) "Possession" or "use" means the joint or individual ownership, control, occupancy,
302
holding, retaining, belonging, maintaining, or the application, inhalation, swallowing,
303
injection, or consumption, as distinguished from distribution, of controlled
304
substances and includes individual, joint, or group possession or use of controlled
305
substances. For a person to be a possessor or user of a controlled substance, it is not
306
required that the person be shown to have individually possessed, used, or controlled
307
the substance, but it is sufficient if it is shown that the person jointly participated with
308
one or more persons in the use, possession, or control of any substances with
309
knowledge that the activity was occurring, or the controlled substance is found in a
310
place or under circumstances indicating that the person had the ability and the intent
311
to exercise dominion and control over [it] the controlled substance.
312
(jj) "Practitioner" means a physician, dentist, naturopathic physician, veterinarian,
313
pharmacist, scientific investigator, pharmacy, hospital, or other person licensed,
314
registered, or otherwise permitted to distribute, dispense, conduct research with
315
respect to, administer, or use in teaching or chemical analysis a controlled substance
316
in the course of professional practice or research in this state.
317
(kk) "Prescribe" means to issue a prescription:
318
(i) orally or in writing; or
319
(ii) by telephone, facsimile transmission, computer, or other electronic means of
320
communication as defined by division rule.
321
(ll) "Prescription" means an order issued:
322
(i) by a licensed practitioner, in the course of that practitioner's professional practice
323
or by collaborative pharmacy practice agreement; and
324
(ii) for a controlled substance or other prescription drug or device for use by a patient
325
or an animal.
326
(mm) "Production" means the manufacture, planting, cultivation, growing, or harvesting
327
of a controlled substance.
328
(nn) "Securities" means any stocks, bonds, notes, or other evidences of debt or of
329
property.
330
(oo) "State" means the state of Utah.
331
(pp) "Ultimate user" means any person who lawfully possesses a controlled substance
332
for the person's own use, for the use of a member of the person's household, or for
333
administration to an animal owned by the person or a member of the person's
334
household.
- 10 - Enrolled Copy H.B. 84
335
(2) If a term used in this chapter is not defined, the definition and terms of Title 76, Utah
336
Criminal Code, shall apply.
337
Section 4. Effective Date.
338
This bill takes effect on May 7, 2025.
- 11 -